Tirzepatide (15MG)
$44.99
Tirzepatide is a synthetic, 39-amino-acid peptide studied for dual activation of GIP and GLP-1 receptors in metabolic signaling.
Description
Certificate of Analysis
Currently in Testing
This batch is currently undergoing independent laboratory testing. Our supplier reports a 100% passing rate on previous testing, and we have chosen to make this product available for sale while the current results are pending. That history does not guarantee this batch’s results. We will publish the batch-specific Certificate of Analysis when testing is complete. If the final results do not meet our quality standards, customers who purchased this batch will receive a full refund.
Compound Information
Technical specifications
Specifications
Peptide class: Synthetic dual GIP/GLP-1 receptor agonist
Length: 39 amino acids
Molecular mass: Approximately 4,813.53 Da
Structure: Linear, fatty-acid-modified peptide
Presentation: 15 mg per individual vial
Sequence
Information
39-residue modified GIP-based peptide; includes Aib residues at positions 2 and 13 and a lipidated Lys20. Full structural sequence and counterion form should be checked against the manufacturer’s analytical records.
Handling & Storage
Confirm product-specific stability data with supplier. Lyophilized material should be protected from moisture and excessive heat; use validated laboratory storage conditions.
Important Research Notice
Research-use material only. Not for human or veterinary use. Not a sterile, FDA-approved medicine. Not intended for diagnosis, treatment, cure, or prevention of disease. Scientific information is provided as educational background, not a claim about this vial’s clinical performance.




